Turnera aphrodisiaca Ward (Turneraceae) has been traditionally used for the treatment of anxiety neurosis and as aphrodisiac, but no attempts have been made to investigate the plant systematically for its traditional claims. The current investigation was carried out ot isolate the bioactive constituent(s) from T. aphrodisiaca using bioactivity-guided fractionation. Antianxiety activityguided fractionation of methanol extract of the plant led to isolation of 5,7,4 0 -trihydroxy flavone apigenin. Its structure was elucidated by UV and NMR data. Apigenin exhibited significant anxiolytic activity at a dose of 2 mg=kg, p.o., in mice using elevated plus maze model of anxiety. It is concluded that apigenin is responsible for anxiolytic effects of this traditionally used plant.
Introduction
Anxiety and insomnia are biological disorders that affect one-eighth of the total population of the world (NIMH, 2002) . Pharmacotherapeutic approaches for the management of these ''modernization-borne diseases'' include psychotropic drugs such as barbiturates, benzodiazepines, azaspirones, norepinephrine and serotonin-reuptake inhibitors, monoamine oxidase inhibitors, and phenothiazines (Baldessarini, 2001) . Among these, benzodiazepines are the most widely prescribed synthetic chemical drugs for the treatment of anxiety, insomnia, epilepsy, and stress. Regular use of benzodiazepines causes deterioration of cognitive functioning, addiction, physical dependence, and tolerance (Council Report, 1997; Longo & Johnson, 2000; Baldessarini, 2001 ). In the light of adverse effects associated with the synthetic drugs, researchers of today are exploring natural resources to discover safer and effective drugs. Investigating plants, based on their use in traditional systems of medicine, is a sound, viable, and cost-effective strategy to develop new drugs (Dhawan, 1995) . A benzoflavone from Passiflora incarnata Linn. (Passifloraceae) aerial parts has been reported, from our laboratory, to be a potential anxiolytic moiety (Dhawan et al., 2001a,b,c) . Continuing the endeavour, Turnera aphrodisiaca Ward was selected for evaluating its anxiolytic potential.
T. aphrodisiaca (synonym T. diffusa willd). (Turneraceae) is commonly known as ''Damiana.'' The leaves of T. aphrodisiaca have been used traditionally as a stimulant, aphrodisiac, tonic, diuretic, nerve tonic, laxative, and in kidney, menstrual, and pregnancy disorders (Hocking, 1955; Parfitt, 1999) . The leaf infusion of Damiana has been used as a traditional remedy in the diseases related to the gastrointestinal and respiratory systems (Caceres, 1996) , reproductive organs (Saggese, 1959) , and for the treatment of gonorrhea in Latin American societies (Koch, 1936) . Damiana has achieved some repute in the treatment of sexual impotence where it is used in conjunction with strychnine, phosphorus, or some other stimulants in homeopathic formulations (Osol et al., 1947) . Mother tincture (85% ethanol extract) of Damiana is an important homeopathic medicine for the treatment of sexual debility and nervous prostration (Boericke, 1988) . The British Herbal Pharmacopoeia (1983) lists specific indications for Damiana as anxiety neurosis associated with impotency and includes other indications such as depression, nervous dyspepsia, atonic constipation, and coital inadequacy.
Phytochemical reports on T. aphrodisiaca indicate that the plant contains tetraphyllin B (cyanoglycoside) (Spencer & Seigler, 1981) ; gonzalitosin I (flavonoid) (Dominguez & Hinojosa, 1976) ; arbutin (phenolic glycoside) (Auterhoff & Hackle, 1968) ; damianin (Steinmetz, 1960) ; tricosan-2-one, hexacosanol (hydrocarbons) (Fryer, 1965) ; a volatile oil containing a-pinene, b-pinene, p-cymene, and 1,8-cineole (Auterhoff & Hackle, 1968) ; and b-sitosterol (phytosterol) (Dominguez & Hinojosa, 1976) .
A survey of the literature on T. aphrodisiaca revealed only three pharmacological reports on the plant. The aqueous extract of T. aphrodisiaca whole plant has been reported to exhibit significant hypoglycemic activity in alloxan-diabetic male mice (Perez et al., 1984) and in rabbits (Aguilara et al., 1998) . The aqueous extract of the plant was reported to exhibit aphrodisiac activity in sexually sluggish male rats at a dose of 1 ml=kg (Arletti et al., 1999) .
Despite a long history of use of T. aphrodisiaca as a traditional medicine for the treatment of various ailments, especially CNS disorders, the plant has never been subjected to CNS activity studies. Recently, authors have reported that among various extracts, viz., petroleum ether, chloroform, methanol, and water, of T. aphrodisiaca aerial parts, only the methanol extract (25 mg=kg, p.o.) exhibited significant antianxiety activity on elevated plus maze model (Kumar & Sharma, 2004) . Thus, it was considered worthwhile to subject the methanol extract of T. aphrodisiaca to antianxiety activityguided fractionation studies.
Materials and Methods

Plant material
T. aphrodisiaca Ward was procured from a cultivated source [Rati Ram Nursery, Village Khurrampur, district Saharanpur (U.P.), India] in August 2002 and was dried in the shade. Identity of the plant was confirmed through Botanical Survey of India (Howrah, India). A voucher specimen of the plant has been deposited in the Herbarium-cum-Museum of the University Institute of Pharmaceutical Sciences, Panjab University (Chandigarh, India).
Animals
Laca mice (either sex), bred at the Central Animal House, Panjab University, Chandigarh, were allowed a standard pellet diet (Ashirwad, Chandigarh, India) and water ad libitum. Groups of five mice (20-24 g) were used in all sets of experiments. The animals were fasted for 18 hours before use. Approval from the Institutional Animal Ethical Committee of Panjab University (Chandigarh, India) was received before carrying out the antianxiety studies.
Solvents
Chloroform (Ranbaxy Laboratory Chemicals, New Delhi, India), methanol, acetonitrile (s.d. Fine Chemicals, Mumbai, India), toluene and acetone (E. Merck, Mumbai, India), all of LR grade, distilled under normal atmospheric pressure, were employed for column and preparative=thin-layer chromatography.
Chemicals and instruments
Keiselguhr white (Loba Chemicals, Mumbai, India) was used for column chromatography. Precoated aluminum TLC sheets (silica gel G, 0.2 mm; E. Merck) and 2 ml capillary tubes (CAMAG) were used for TLC studies. The thin-layer chromatograms were visualized under 254=366 nm UV light (DESAGA, Heidelberg, Germany, Min. UVIS [Ultraviolet Imaging Spectrograph] ) and also by spraying with 60% v=v aqueous sulfuric acid (E. Merck). Melting point was determined with Rescholar melting point apparatus (Ambala, India). UV spectra was obtained on a Perkin Elmer Hitachi 330, Switzerland (Lambda 15 UV=VIS) spectrophotometer. NMR spectra were run on a Bruker spectrometer (Switzerland) at 300 MHz.
Preparative thin-layer chromatography
Preparative thin-layer chromatography was performed using 20 Â 20 glass plates coated with 0.5-mm silica gel G (E. Merck).
Vehicle and standard
Simple syrup I.P. þ Tween 80 (5%) was used as vehicle for preparing the suspension of various test doses. Diazepam (2 mg=kg, p.o.) (Triko Pharmaceuticals, Rohtak, Haryana, India), suspended in vehicle, was used as standard anxiolytic drug.
Preparation of doses
Test doses of various fractions and subfractions of methanol extract of T. aphrodisiaca were prepared by suspending in the vehicle in such concentrations as to treat mice with a volume ranging from 0.20 to 0.24 ml per oral route.
Statistics
The results were expressed as mean AE standard error of mean (SEM). The test doses were compared with diazepam and control by analysis of variance (ANOVA) followed by Studentized Tukey's test (Scheffer, 1980) .
Elevated plus maze model of anxiety
The plus maze apparatus, consisting of two open arms (16 Â 5 cm) and two closed arms (16 Â 5 Â 12 cm) having an open roof, with the plus maze elevated (25 cm) from the floor, was used to observe anxiolytic behavior in animals (Kulkarni, 2003) . Each mouse was placed at the center of the elevated plus maze with its head facing the open arms. During a 5-min experiment, the behavior Various fractions and bioactive constituent of T. aphrodisiaca methanol extract were administered orally using a tuberculin syringe fitted with oral canula. Dose administration schedule was so adjusted that each mouse was having its turn on the elevated plus maze apparatus 45 min after the administration of the dose. During the entire experiment, the animals were allowed to socialize. Every precaution was taken to ensure that no external stimuli, other than the height of plus maze, could invoke anxiety in the animals.
Preparation of methanol extract of T. aphrodisiaca Powdered aerial parts (2.5 kg) of T. aphrodisiaca were successively extracted in a Soxhlet apparatus using the solvents in order of increasing polarity, viz., petroleum ether (60-80 C), chloroform, and methanol. The yield of methanol extract of T. aphrodisiaca aerial parts was found to be 12.10% w=w.
Fractionation of methanol extract
The methanol extract (250 g) of T. aphrodisiaca was loaded onto a column packed with Keiselguhr white and eluted with chloroform, chloroform-methanol, and methanol-acetonitrile solvent systems. A total of 130 fractions, 250 ml each, were collected. These were pooled, based on similar thin-layer chromatograms, to get 7 fractions (F 5.1 -F 5.7 ), which were evaluated for antianxiety activity at various doses (5, 10, 15, 20, or 25 mg=kg, p.o.) using elevated plus maze apparatus.
The bioactive fraction F 5 (75 g) was subjected to phytochemical screening (Farnsworth, 1966) and column chromatographed over Keiselguhr white. Elution was done with chloroform and chloroform-methanol to get 7 pooled subfractions (F 5.1 -F 5.7 ). These were evaluated for anxiolytic activity at various doses (i.e., 1, 2, 5, 10, or 20 mg=kg, p.o.).
Bioactive subfraction 7.3 (F 5.3 ) was also subjected to phytochemical screening (Farnsworth, 1966) . Thin-layer chromatography of F 5.3 using mobile phase toluene: chloroform: acetone: 8:5:7 showed two spots. Repeated preparative thin-layer chromatography of F 5.3 using the solvent system toluene:chloroform:acetone, 8:5:7, yielded two pure isolates K 1 (72 mg) and K 2 (13 mg), which were evaluated for antianxiety activity at the dose levels of 0.5, 1.0, 2.0, or 5.0 mg=kg, p.o.
Characterization of K 1 K 1 was characterized on the basis of its melting point, UV, 1 H NMR, and 13 C NMR spectra, and by comparison with that of the reference standard of apigenin (Sigma-Aldrich, St. Louis, USA).
Results
Results of column chromatography of methanol extract of T. aphrodisiaca and the antianxiety activity profile of F 1 -F 7 are shown in Table 1 . Phytochemical screening of F 5 showed that the fraction contained alkaloids and flavonoids. Results of column chromatography of F 5 , and antianxiety activity of F 5.1 -F 5.7 are shown in Table 2 . Subfraction F 5.3 , when subjected to qualitative phytochemical screening, tested positive only for flavonoids. Antianxiety activity profile of K 1 and K 2 is reported in Table 3 .
Discussion
Antianxiety activity of various fractions and bioactive constituent of methanol extract of T. aphrodisiaca aerial parts was evaluated employing a widely used model (i.e., elevated plus maze). The model was chosen because it is effective, cheap, simple, less time consuming, requires no preliminary training for the mice, and does not cause much discomfort to the animals while handling. The model is principally based on the observations that exposure of animals to an elevated and open maze results in approach-avoidance conflict, which is manifested as an exploratory-cum-fear drive. The fear due to height (acrophobia) induces anxiety in the animals when placed on the elevated plus maze. The ultimate manifestation of anxiety and fear in the animals is exhibited by decrease in motor activity, which is measured by the time spent by the animal in the open arms.
Out of the four extracts, viz., petroleum ether, chloroform, methanol, and water, of T. aphrodisiaca, the methanol extract exhibited significant anxiolytic activity (Kumar & Sharma, 2004) . Therefore, the methanol extract of the plant was selected for bioactivity-guided fractionation. Column chromatography of the methanol extract afforded bioactive fraction F 5 , which tested positive for alkaloids and flavonoids. F 5 exhibited significant antianxiety activity at a dose of 10 mg=kg, p.o., using elevated plus maze model of anxiety (Table 1) . Column chromatography of F 5 yielded 7 subfractions out of which only F 5.3 exhibited significant anxiolytic activity at a dose of 5 mg=kg, p.o. (Table 2 ). F 5.3 gave positive test only for flavonoids. Repeated preparative thin-layer chromatography of F 5.3 led to the isolation of two pure compounds, K 1 (72 mg) and K 2 (13 mg). K 1 exerted significant anxiolytic effects, which were comparable with those of the control as well as the standard (diazepam), at a dose of 2 mg=kg, p.o. (Table 3) . K 2 was found to be devoid of antianxiety activity (Table 3) . A dose dependent decrease in antianxiety activity was observed at higher doses of F 5 (15, 20, or 25 mg=kg, p.o.) , F 5.3 (10 or 20 mg=kg, p.o.) and K 1 (5 mg=kg, p.o.). We suggest that these effects might be due to mild sedation in mice at higher doses. The structure of K 1 was elucidated by UV, 1 H NMR, and 13 C NMR spectral data and characterized as 5,7,4 0 -trihydroxy flavone, that is, (apigenin) (Mabry et al., 1970; Viola et al., 1995; Owen et al., 2003) . Further, the identity of K 1 was confirmed by comparison of its spectral data with that of reference standard of apigenin. Because the quantity of K 2 generated, following column and preparative thin-layer chromatography, was not sufficient to perform its spectral analysis, its structure was not established. Our findings are in agreement with those of Viola et al. (1995) and Salguiero et al. (1997) who have reported that apigenin exhibits anxiolytic activity at a dose of 3 mg=kg, i.p., and mild sedative activity at higher doses. In the light of the above findings, it is concluded that apigenin is responsible for the antianxiety activity of T. aphrodisiaca.
